These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 35957578)

  • 1. Qualitative Olfactory Dysfunction and COVID-19: An Evidence-Based Review with Recommendations for the Clinician.
    Gary JB; Gallagher L; Joseph PV; Reed D; Gudis DA; Overdevest JB
    Am J Rhinol Allergy; 2023 Jan; 37(1):95-101. PubMed ID: 35957578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A follow-up on quantitative and qualitative olfactory dysfunction and other symptoms in patients recovering from COVID-19 smell loss.
    Ohla K; Veldhuizen MG; Green T; Hannum ME; Bakke AJ; Moein ST; Tognetti A; Postma EM; Pellegrino R; Hwang DLD; Albayay J; Koyama S; Nolden AA; Thomas-Danguin T; Mucignat-Caretta C; Menger NS; Croijmans I; Ã-ztà Rk L; YanÄ K H; Pierron D; Pereda-Loth V; Nunez-Parra A; Martinez Pineda AM; Gillespie D; Farruggia MC; Cecchetto C; Fornazieri MA; Philpott C; Voznessenskaya V; Cooper KW; Rohlfs Dominguez P; Calcinoni O; de Groot J; Boesveldt S; Bhutani S; Weir EM; Exten C; Joseph PV; Parma V; Hayes JE; Niv MY
    Rhinology; 2022 Jun; 60(3):207-217. PubMed ID: 35398877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proof-of-concept: SCENTinel 1.1 rapidly discriminates COVID-19-related olfactory disorders.
    Hunter SR; Hannum ME; Pellegrino R; O'Leary MA; Rawson NE; Reed DR; Dalton PH; Parma V
    Chem Senses; 2023 Jan; 48():. PubMed ID: 36796784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction.
    O'Byrne L; Webster KE; MacKeith S; Philpott C; Hopkins C; Burton MJ
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013876. PubMed ID: 34291813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Post-Infectious Anosmia and Hyposmia: A Systematic Review.
    Nag AK; Saltagi AK; Saltagi MZ; Wu AW; Higgins TS; Knisely A; Ting JY; Illing EA
    Ann Otol Rhinol Laryngol; 2023 Jul; 132(7):806-817. PubMed ID: 35959948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Features of Parosmia Associated With COVID-19 Infection.
    Lerner DK; Garvey KL; Arrighi-Allisan AE; Filimonov A; Filip P; Shah J; Tweel B; Del Signore A; Schaberg M; Colley P; Govindaraj S; Iloreta AM
    Laryngoscope; 2022 Mar; 132(3):633-639. PubMed ID: 34870334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent COVID-19 parosmia and olfactory loss post olfactory training: randomized clinical trial comparing central and peripheral-acting therapeutics.
    Cantone E; D'Ascanio L; De Luca P; Roccamatisi D; La La Mantia I; Brenner MJ; Di Stadio A
    Eur Arch Otorhinolaryngol; 2024 Jul; 281(7):3671-3678. PubMed ID: 38492007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis and Therapy of Olfactory Dysfunction - State of the ArtThe neglected sense-new evidence highlights the significance of the human sense of smell].
    Müller CA; Renner B
    Wien Med Wochenschr; 2022 Feb; 172(1-2):8-13. PubMed ID: 34851470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and correlates of parosmia and phantosmia among smell disorders.
    Pellegrino R; Mainland JD; Kelly CE; Parker JK; Hummel T
    Chem Senses; 2021 Jan; 46():. PubMed ID: 34698820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction.
    Webster KE; O'Byrne L; MacKeith S; Philpott C; Hopkins C; Burton MJ
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD013877. PubMed ID: 36063364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Qualitative smell/taste disorders as sequelae of acute COVID-19.
    Ercoli T; Masala C; Pinna I; Orofino G; Solla P; Rocchi L; Defazio G
    Neurol Sci; 2021 Dec; 42(12):4921-4926. PubMed ID: 34557966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and associated factors of qualitative olfactory dysfunction.
    Eo TS; Lee HY; Cho HJ; Yoon JH; Rha MS; Kim CH
    Rhinology; 2023 Oct; 61(5):432-440. PubMed ID: 37243721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remote psychophysical testing of smell in patients with persistent olfactory dysfunction after COVID-19.
    Martončíková M; Doležal P; Fabianová K; Karhánek M; Gálik J; Raček A; Popovičová A; Račeková E
    Sci Rep; 2023 Aug; 13(1):14090. PubMed ID: 37640847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parosmia in patients with post-infectious olfactory dysfunction in the era of COVID-19-associated olfactory impairment.
    Gunder N; Hummel T
    HNO; 2024 Sep; 72(9):649-656. PubMed ID: 38935276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction.
    Webster KE; O'Byrne L; MacKeith S; Philpott C; Hopkins C; Burton MJ
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013877. PubMed ID: 34291812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Parosmia and phantosmia: clinical update].
    Macario S; Hsieh JW; Daskalou D; Voruz F; Landis BN
    Rev Med Suisse; 2022 Oct; 18(798):1837-1842. PubMed ID: 36200960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction.
    O'Byrne L; Webster KE; MacKeith S; Philpott C; Hopkins C; Burton MJ
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD013876. PubMed ID: 36062970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Objective Sensory Testing Methods Reveal a Higher Prevalence of Olfactory Loss in COVID-19-Positive Patients Compared to Subjective Methods: A Systematic Review and Meta-Analysis.
    Hannum ME; Ramirez VA; Lipson SJ; Herriman RD; Toskala AK; Lin C; Joseph PV; Reed DR
    Chem Senses; 2020 Dec; 45(9):865-874. PubMed ID: 33245136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proof-of-concept: SCENTinel 1.1 rapidly discriminates COVID-19 related olfactory disorders.
    Hunter SR; Hannum ME; Pellegrino R; O'Leary MA; Rawson NE; Reed DR; Dalton PH; Parma V
    medRxiv; 2022 Nov; ():. PubMed ID: 35350197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementing a COVID-19 specialist smell clinic: experience at the Wrightington, Wigan and Leigh Teaching Hospitals (WWL), NHS Foundation Trust, United Kingdom.
    Chu M; Gopikrishna D; Rocke J; Kumar BN
    Med J Malaysia; 2021 Aug; 76(Suppl 4):9-13. PubMed ID: 34558550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.